Ancora Advisors, LLC Sage Therapeutics, Inc. Transaction History

Ancora Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$17.1 - $22.26 $1,710 - $2,226	-100 Reduced 57.14%	75 $1,000
Q1 2023 May 15, 2023	SELL	$37.27 - $46.57 $372 - $465	-10 Reduced 5.41%	175 $7,000
Q3 2022 Nov 14, 2022	BUY	$32.28 - $43.27 $322 - $432	10 Added 5.71%	185 $7,000
Q2 2022 Aug 15, 2022	SELL	$27.52 - $37.99 $522 - $721	-19 Reduced 9.79%	175 $5,000
Q1 2022 May 16, 2022	BUY	$30.71 - $45.71 $583 - $868	19 Added 10.86%	194 $6,000
Q1 2020 May 14, 2020	SELL	$26.15 - $77.24 $784 - $2,317	-30 Reduced 14.63%	175 $5,000
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $12,336 - $31,727	205 New	205 $15,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $330M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Ancora Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ancora Advisors, LLC with notifications on news.